OnKure Therapeutics, Inc.
OKUR
Last
$2.40
Day
+4.3%
1y
-26.5%
5y
-66.2%
52w
-57.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0526d
EMA 21
2.77
EMA 50
3.22
EMA 200
3.70
20d high
-29.0%
5y high
-88.5%
5y range
3th
Positions held
Your positionsOKUR isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$2.76
Stop
$1.92
Stop distance
20.0%
Target vs last
+15.0%
Fundamentals
| Market cap | $93.14M | Enterprise value | -$82.32M | Trailing P/E | — | Forward P/E | -1.51 |
| PEG | — | Price / book | 0.54 | Beta | 0.75 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -46.9% | ROA | -29.3% | Debt / equity | 0.01 |
| Current ratio | 26.75 | Free cash flow | -$27.11M | Analyst recommendation | none | Mean target | $15.50 |
| 52w high | $5.38 | 52w low | $2.13 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | -$15.3M | -$15.2M | -$13.5M | -$14.7M | -$15.4M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$16.9M | -$15.6M | -$14.1M | -$15.5M | -$16.3M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$59.5M | -$52.7M | -$35.3M | -$29.5M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$63.0M | -$54.4M | -$36.9M | -$29.8M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-08-31 · OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
2026-08-04 · OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
2026-07-15 · OnKure Therapeutics Spotlights Allosteric PI3Kα Drugs as 2027 IND Targets Near
Price (daily)
Full chart · RSI · MACD · patternsOKUR · daily-25.8% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin